BridgeBio Pharma Inc (NASDAQ:BBIO)

11.81
Delayed Data
As of Feb 07
 +0.37 / +3.23%
Today’s Change
4.98
Today|||52-Week Range
12.64
+54.99%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale1/05/2023120,000$7.67$920.4K+53.78%
Stephenson Brian C
Chief Financial Officer & Secretary
Sale1/05/202361,040$7.67$468.2K+53.78%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale11/16/202234,066$9.64$328.4K+22.51%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale11/17/202234,640$9.40$325.6K+22.38%
Stephenson Brian C
Chief Financial Officer & Secretary
Sale11/17/202219,678$9.40$185.0K+22.38%
Kumar Neil /bridgebio/
President & Chief Executive Officer
Sale5/16/202223,759$6.74$160.1K+75.22%
Stephenson Brian C
Chief Financial Officer & Secretary
Sale11/16/202210,789$9.64$104.0K+22.51%
Ellis Andrea
Director
Buy3/15/202212,000$8.39$100.7K+38.78%
Dachille Douglas Adam
Director
Buy3/14/202210,000$8.19$81.9K+43.15%
Stephenson Brian C
Corporate Officer
Sale5/16/20229,228$6.74$62.2K+75.22%
Page of 3